Ulrich Schubert
Heinrich Pette Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ulrich Schubert.
Nature | 2000
Ulrich Schubert; Luis C. Antón; James Gibbs; Christopher C. Norbury; Jonathan W. Yewdell; Jack R. Bennink
MHC class I molecules function to present peptides eight to ten residues long to the immune system. These peptides originate primarily from a cytosolic pool of proteins through the actions of proteasomes, and are transported into the endoplasmic reticulum, where they assemble with nascent class I molecules. Most peptides are generated from proteins that are apparently metabolically stable. To explain this, we previously proposed that peptides arise from proteasomal degradation of defective ribosomal products (DRiPs). DRiPs are polypeptides that never attain native structure owing to errors in translation or post-translational processes necessary for proper protein folding. Here we show, first, that DRiPs constitute upwards of 30% of newly synthesized proteins as determined in a variety of cell types; second, that at least some DRiPs represent ubiquitinated proteins; and last, that ubiquitinated DRiPs are formed from human immunodeficiency virus Gag polyprotein, a long-lived viral protein that serves as a source of antigenic peptides.
Nature Medicine | 2001
Weisan Chen; Paul A. Calvo; Daniela Malide; James Gibbs; Ulrich Schubert; Igor Bacik; Sameh Basta; Robert E. O'Neill; Jeanne H. Schickli; Peter Palese; Peter Henklein; Jack R. Bennink; Jonathan W. Yewdell
While searching for alternative reading-frame peptides encoded by influenza A virus that are recognized by CD8+ T cells, we found an abundant immunogenic peptide encoded by the +1 reading frame of PB1. This peptide derives from a novel conserved 87-residue protein, PB1-F2, which has several unusual features compared with other influenza gene products in addition to its mode of translation. These include its absence from some animal (particularly swine) influenza virus isolates, variable expression in individual infected cells, rapid proteasome-dependent degradation and mitochondrial localization. Exposure of cells to a synthetic version of PB1-F2 induces apoptosis, and influenza viruses with targeted mutations that interfere with PB1-F2 expression induce less extensive apoptosis in human monocytic cells than those with intact PB1-F2. We propose that PB1-F2 functions to kill host immune cells responding to influenza virus infection.
FEBS Letters | 2000
Peter Henklein; Rudolf Kinder; Ulrich Schubert; Burkhard Bechinger
The cytoplasmic domain of the HIV‐1 accessory protein Vpu is involved in the binding and degradation of the viral receptor CD4. In order to analyze previous structural models in the context of membrane environments, regions of VpuCYTO incorporating particular conformational features have been synthesized and labelled with 15N at selected backbone amides. Well‐oriented proton‐decoupled 15N solid‐state NMR spectra with 15N chemical shifts at the most upfield position indicate that the amphipathic helix within [15N‐Leu 45]‐Vpu27–57 strongly interacts with mechanically aligned POPC bilayers and adopts an orientation parallel to the membrane surface. No major changes in the topology of this membrane‐associated amphipathic helix were observed upon phosphorylation of serine residues 52 and 56, although this modification regulates biological function of Vpu. In contrast, [15N‐Ala 62]‐Vpu51–81 exhibits a pronounced 15N chemical shift anisotropy.
Handbook of Biologically Active Peptides | 2006
Jörg Votteler; Karsten Bruns; Peter Henklein; Victor Wray; Ulrich Schubert
ABSTRACT Efficient solid-state synthesis now affords ready access, particularly in situations in which recombinant protocols usually fail, to high-quality synthetic peptides that are equivalent to many full-length biologically active systems or domains thereof, including posttranslational modifications such as phosphorylation and acetylation. Here we survey recent applications of such peptides to the investigations of human immunodeficiency viruses (HIV), with the focus on the regulatory peptides Vpu, Vpr, and Tat, as well as the protease, the Gag peptides nucleocapsid, matrix, and p6 from HIV-1. The importance of the full-length synthetic viral peptides for molecular characterization that involves both detailed biochemical and structural studies at the atomic level and their potential for therapeutic applications are emphasized.
Archive | 2005
Ulrich Schubert; Hans Will; Hüseyin Sirma
Archive | 2003
Ulrich Schubert; Evelyn Schubert; Uwe Tessmer; Kerstin Lucas
Archive | 2002
Michael P. Sherman; Warner C. Greene; Ulrich Schubert; Victor Wray; Uwe Tessmer; Peter Henklein; Karsten Bruns
Archive | 2004
Hans Will; Uwe Tessmer; Karsten Bruns; Ulrich Schubert
Archive | 2008
Heinz Hohenberg; Alexij Prassalow; Evelyn Schubert; Ulrich Schubert; Hueseyin Sirma; Uwe Tessmer; Reinhold Welker; Hans Will; プラソロフ アレクシイ; テスマー ウーヴェ; シューベルト ウルリヒ; シューベルト エヴェリン; ホーエンベルク ハインツ; ヴィル ハンス; ジルマ ヒュセイン; ヴェルカー ラインホルト
Archive | 2002
Karsten Bruns; Warner C. Greene; Peter Henklein; Ulrich Schubert; Michael P. Sherman; Uwe Tessmer; Victor Wray